9.4 Special Arrest Circumstances: Opioids, Anaphylaxis, Drowning & Hypothermia

Special Arrest Circumstances: Opioids, Anaphylaxis, Drowning & Hypothermia

While standard Advanced Cardiovascular Life Support (ACLS) algorithms guide the management of most cardiac arrests, specific underlying etiologies involve distinct pathophysiological mechanisms that mandate specialized treatment protocols. The 2025 American Heart Association (AHA) Guidelines establish clear, evidence-based modifications for resuscitation in special circumstances, including opioid overdose, severe anaphylaxis, drowning, and accidental hypothermia.

---

Opioid-Associated Resuscitation Emergencies

The ongoing opioid epidemic has made opioid-associated respiratory arrest and secondary cardiac arrest a frequent emergency presentation. Opioids (such as fentanyl, heroin, oxycodone, and methadone) bind to mu-opioid receptors in the central nervous system, producing profound respiratory depression, hypercapnia, hypoxia, and eventual cardiac arrest.

Resuscitation Priorities: CPR First

A critical clinical rule in opioid-associated cardiac arrest is that high-quality CPR (chest compressions and ventilation) takes absolute priority over antidote administration.

When a patient is in full cardiac arrest, systemic blood flow is zero. Administering naloxone (intranasal or intravenous) to a pulseless patient will not reverse the arrest because the drug cannot circulate to central nervous system receptors without blood flow generated by chest compressions. Furthermore, the immediate cause of cardiac arrest in opioid toxicity is severe tissue hypoxia, which must be reversed via high-quality ventilations and compressions.

• Naloxone Dosing & Administration: Naloxone (0.4 to 2 mg IV/IM, or 2 to 4 mg intranasal) should be administered as soon as available, but its administration must occur concurrently with CPR without causing pauses in chest compressions or delaying defibrillation.
• Post-ROSC Monitoring: Naloxone has a relatively short duration of action (30 to 90 minutes). Many synthetic opioids (particularly long-acting formulations or potent fentanyl analogs) have elimination half-lives that far exceed naloxone. Patients who achieve Return of Spontaneous Circulation (ROSC) following naloxone administration are at high risk for recurrent, severe respiratory depression and re-arrest. Continuous monitoring in an intensive care setting for at least 4 to 6 hours post-ROSC is mandatory.

---

Anaphylaxis & Anaphylactic Shock

Anaphylaxis is a severe, systemic IgE-mediated hypersensitivity reaction characterized by rapid-onset airway obstruction, severe bronchospasm, and profound distributive (vasoplegic) shock. Cardiac arrest in anaphylaxis results from a combination of asphyxia (laryngeal edema) and catastrophic loss of vascular tone with capillary leakage.

First-Line Epinephrine Administration

In severe anaphylaxis and impending respiratory/cardiac arrest, Intramuscular (IM) Epinephrine is the primary, life-saving intervention:

• Dose & Route: Administer 0.3 to 0.5 mg of Epinephrine 1:1,000 (1 mg/mL) IM into the anterolateral mid-thigh (vastus lateralis). The anterolateral thigh provides rapid vascular absorption and higher peak plasma concentrations compared to subcutaneous or deltoid injection.
• Repeat Dosing: The IM dose may be repeated every 5 to 15 minutes if clinical improvement is insufficient.
• IV Epinephrine Infusion: In severe anaphylactic shock refractory to IM injections, transition to a continuous IV Epinephrine infusion (titrated to MAP ≥65 mmHg). In full cardiac arrest, standard ACLS IV Epinephrine (1 mg 1:10,000 IV every 3-5 minutes) is administered.

Airway Management & Volume Resuscitation

• Aggressive Crystalloid Resuscitation: Anaphylaxis causes massive intravascular fluid shifts into the interstitial space (up to 35% of circulating volume can be lost in minutes). Rapid IV boluses of 2 to 4 Liters of isotonic crystalloid (Normal Saline or Lactated Ringer's) are required.
• Early Advanced Airway Insertion: Progressive laryngeal and pharyngeal edema can rapidly obliterate upper airway anatomy. An advanced airway (endotracheal tube) must be secured as early as possible by the most experienced clinician available. If complete upper airway obstruction occurs, surgical cricothyroidotomy must be performed immediately.

---

Drowning Resuscitation Protocols

Drowning is defined as the process of experiencing respiratory impairment from submersion or immersion in liquid. The primary mechanism of cardiac arrest in drowning is asphyxial hypoxia, leading to cardiac ischemia, bradycardia, PEA, and eventual asystole.

Ventilations-First Resuscitation Sequence

Because drowning is fundamentally an hypoxic event, resuscitation protocols prioritize immediate oxygenation and ventilation over compressions-only CPR:

• Five Initial Rescue Breaths: Rescuers should initiate resuscitation by delivering 5 initial rescue breaths (using mouth-to-mask or bag-valve-mask with 100% oxygen) as soon as the victim is removed from the water. Supplemental oxygenation relieves alveolar hypoxia and restores coronary oxygen delivery.
• Standard 30:2 CPR Ratio: Following the 5 initial breaths, rescuers initiate standard CPR cycles of 30 chest compressions to 2 ventilations. Compressions-only CPR is inappropriate for drowning victims.
• Cervical Spine Management: Routine cervical spine immobilization is NOT recommended for drowning victims unless clear history indicates diving trauma, high-velocity water sports, or fall from height. Cervical collars complicate airway management and delay rescue breathing.

---

Severe Accidental Hypothermia (<30°C / 86°F)

Accidental hypothermia occurs when core body temperature drops below 35°C (95°F), with severe hypothermia defined as core temperature <30°C (86°F). Hypothermia depresses cellular metabolism, offering significant neuroprotection; however, severe hypothermia renders the myocardium irritable, rigid, and refractory to electrical defibrillation and resuscitation drugs.

Modified ACLS Guidelines for Severe Hypothermia (<30°C)

1. Defibrillation Limit (1 Shock): If VF or pulseless VT is detected on the monitor, deliver 1 shock. If the shock fails to convert the rhythm, further defibrillation attempts should be deferred until core body temperature is rewarmed above 30°C (86°F). Repeated shocks across a severely hypothermic heart cause tissue damage without converting the rhythm.
2. Withholding Resuscitative Medications: IV resuscitation drugs (Epinephrine, Amiodarone, Lidocaine) should be withheld when core body temperature is <30°C. Below 30°C, hepatic and renal drug metabolism is virtually halted. Administering repeated doses of epinephrine results in drug accumulation; as the patient rewarms, accumulated drugs enter active circulation simultaneously, causing lethal vasopressor toxicity and refractory arrhythmias. Once core temp reaches 30°C to 35°C, drug dosing intervals should be doubled (e.g., Epinephrine every 6 to 10 minutes).
3. Active Core Rewarming: High-priority active internal rewarming must be initiated immediately:
   • Administration of warmed IV crystalloid fluids (42°C / 107.6°F).
   • Warmed, humidified oxygen via advanced airway.
   • Pleural, peritoneal, or bladder lavage with warm isotonic fluids.
   • Extracorporeal Life Support (ECLS) / ECMO or cardiopulmonary bypass in specialized centers.
4. Resuscitation Futility Rule: Resuscitation must be continued continuously during rewarming. A hypothermic cardiac arrest patient should not be declared dead until active rewarming to a core temperature of ≥32°C to 35°C has been achieved without ROSC—giving rise to the clinical axiom: "A patient is not dead until warm and dead."